Gyre Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $55.7M
Liabilities Breakdown FY2021
Total Liabilities: $14.6M
Asset Breakdown
Total Assets: $55.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $44.3M | 79.7% |
| Accounts Receivable | $1.8M | 3.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $970.0K | 1.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.5M | 15.3% |
Liabilities Breakdown
Total Liabilities: $14.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.4M | 44.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.2M | 56.0% |